February 9, 2016 / 4:07 PM / in 2 years

Katusha team escape suspension after doping tests

(Reuters) - The Katusha World Tour cycling team have escaped suspension despite two of their riders failing drugs tests in the space of a year, the International Cycling Union (UCI) said on Tuesday after a disciplinary commission hearing.

Katusha rider Luca Paolini of Italy poses during the Tour de France cycling race presentation in Utrecht, Netherlands, July 2, 2015. REUTERS/Benoit Tessier

The regulations stipulate that a team, once all circumstances have been considered, shall be suspended if two of their riders test for a prohibited substance within a 12-month period.

The commission ruled, however, that the conditions for a suspension of the Russian team had not been met because the first positive test involving Italian Luca Paolini was for cocaine taken on a recreational basis.

”Even if, strictly speaking, such a case falls within the application of the anti-doping rules for the rider concerned, the imposition of negative consequences for the whole team would be inappropriate and disproportionate,” it said in a statement.

“The President of the Commission has expressed that he could share the view that it would be disproportionate to suspend a team on the basis that one of its members (uses) a social drug, the consumption of which is not related to sporting performance.”

Paolini tested positive during last year’s Tour de France.

Russian Eduard Vorganov failed an out-of-competition test on Jan. 14 for Meldonium, a substance that helps recovery and protects against stress which was added to the World Anti-Doping Agency’s prohibited list on Jan. 1.

Reporting by Alan Baldwin, editing by Ed Osmond

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below